Highest-materiality recent filing
WisdomTree Q2: EPS $0.28, record AUM $162.9B, operating margin 40.5%
Net income $44.3M ($0.28 diluted EPS); adjusted net income $48.1M ($0.31 adjusted EPS).
WisdomTree shareholders elect all 9 director nominees, ratify EY, approve say-on-pay
All nine director nominees elected with between 97.3% and 99.9% of votes cast for.
WisdomTree to repurchase $51.9M of its 3.25% Convertible Notes due 2029 for ~$87.3M
Repurchases $51.9M aggregate principal of 3.25% Convertible Senior Notes due 2029 for cash of ~$87.3M.
Net loss $23.1M ($0.17 diluted loss); adjusted net income $40.6M ($0.27 adjusted EPS).
WisdomTree issues $603.75M of 4.50% convertible notes due 2031, nets ~$591.2M
Aggregate principal $603.75M, 4.50% interest, semiannual, matures October 1, 2031.
WisdomTree prices $603.75M 4.50% convertible notes, exchanges $350M existing notes
Priced $603.75M (incl. full greenshoe) of 4.50% convertible senior notes due 2031; net proceeds ~$591.2M.
Principal amount $525M (plus $78.75M option) of convertible senior notes due 2031 in a private offering.
Purchase price £150M (~$200M) cash; expected close in Q2 2026 subject to regulatory approvals and financing.
WisdomTree Q4 2025: diluted EPS $0.28, record AUM $144.5B, dividend $0.03
Q4 2025 diluted EPS $0.28 ($0.29 adjusted); net income $40.0M ($41.2M adjusted).
WisdomTree Q3 2025: Record AUM $137.2B, adj EPS $0.23, raises buyback by $190M
Net income $19.7M ($34.5M adj); diluted EPS $0.13 ($0.23 adj); revenue $125.6M (+11.5% QoQ).
Acquisition closed Oct 1, 2025; $275M cash paid at closing, subject to adjustments, plus earnout up to $225M in 2030.
WisdomTree issues $475M of 4.625% convertible notes due 2030, net proceeds ~$464M
Issued $475M principal of 4.625% Convertible Senior Notes due Aug 15, 2030; net proceeds ~$464M.
Priced $475M aggregate convertible senior notes due 2030 (4.625% interest, conversion price $19.1545, 45% premium).
Offering of $400M convertible senior notes due 2030; underwriters option for additional $60M.
WisdomTree to acquire Ceres Partners for $500M; Q2 EPS $0.17, AUM $126.1B
Acquisition of Ceres Partners for $275M cash upfront plus up to $225M earnout in 2030; expected close Q4 2025.
WisdomTree stockholders elect all nine director nominees, ratify EY, approve say-on-pay
Nine directors elected with 89.8% to 99.4% of votes cast; all to serve until 2026 annual meeting.
WisdomTree reports Q1 2025 record AUM of $115.8B; diluted EPS $0.17
Net income of $24.6M ($0.17 diluted EPS); adjusted net income of $23.0M ($0.16 diluted EPS).
WisdomTree eliminates Series B Preferred Stock references after rights agreement expiration
Stockholder Rights Agreement expired March 17, 2025, ending associated preferred stock purchase rights.
WisdomTree Q4 EPS $0.18 ($0.17 adj); revenue $110.7M; AUM $109.8B; dividend $0.03
Diluted EPS $0.18, adjusted $0.17; net income $27.3M, adjusted $25.3M.
WisdomTree appoints Smita Conjeevaram as Board Chair, succeeds Win Neuger
Smita Conjeevaram appointed Chair of the Board effective January 23, 2025.
WisdomTree Q3 AUM record $112.6B; adjusted EPS $0.18, GAAP loss -$0.13 on debt extinguishment
Record AUM of $112.6B; net outflows of $2.4B, primarily international developed equity and fixed income.
WisdomTree settles SEC ESG enforcement action, pays $4M penalty
WTAM received Wells Notice on Aug 5, 2024, over three ESG-focused funds launched Mar 2020 and liquidated Feb 2024.
WisdomTree issues $345M 3.25% convertible notes due 2029, repurchases all Series A preferred stock
$345M aggregate principal of 3.25% Convertible Senior Notes due 2029 issued; net proceeds ~$337M.
WisdomTree prices $345M convertible notes, 9% EPS-accretive Series A buyback
WisdomTree priced $300M (with $45M greenshoe exercised) of 3.25% convertible notes due 2029; conversion price $11.82/share (22.5% premium).
Agreed to buy back 14,750 Series A Preferred shares (convertible into 14.75M common shares) from ETFS Capital for ~$144M cash.
WisdomTree subsidiary receives SEC Wells Notice over ESG fund disclosures
SEC staff issued a Wells Notice to WisdomTree Asset Management alleging securities law violations related to three ESG-focused ETFs.
WisdomTree Q2 2024: record AUM $109.7B, diluted EPS $0.13 ($0.16 adjusted)
Record AUM of $109.7B, up 2.3% QoQ on market appreciation and net inflows.
WisdomTree stockholders elect all nine board nominees, pass all proposals at 2024 annual meeting
All nine director nominees elected with 84.8% to 99.8% of votes cast; final results pending certification.
On April 30, 2024, WisdomTree entered into Amendment No. 5 to its Stockholder Rights Agreement with Continental Stock Transfer & Trust.
WisdomTree Q1 2024: Record AUM $107.2B, EPS $0.13 ($0.12 adj), dividend $0.03
Record AUM $107.2B (+7.1% QoQ); net inflows $2.0B for the quarter.
WisdomTree amends 2023 rights agreement; redefines 'Beneficial Owner' language
Amendment No. 4 to Stockholder Rights Agreement dated March 17, 2023, entered March 25, 2024.
WisdomTree extends poison pill to March 2025, raises exercise price to $45
Rights plan extended to March 17, 2025, subject to stockholder ratification at 2024 annual meeting.
Board unanimously rejected Graham Tuckwell's three proposals: replace CEO, raise outside money for WisdomTree Prime, and appoint investment bank for strategic alternatives.
WisdomTree Q4 net income $19.1M; AUM surpasses $100B; adjusted EPS $0.11
Q4 net income $19.1M (adj. $18.6M); diluted EPS $0.16 (adj. $0.11); operating margin 28.7%.
Repurchased 13,087 Series C Preferred shares (convertible into 13.1M common) for ~$84.4M cash.
Director Harold Singleton III resigns; Lynn Blake named audit chair, Rilla Delorier joins committee
Harold Singleton III resigned from WisdomTree board effective Nov. 8, 2023, citing a conflict from joining a mutual fund board.
WisdomTree Q3 2023: adj EPS $0.10, op margin 29.5% (+900bps YoY), $2B inflows
Net income $13.0M ($0.07 diluted EPS); adjusted net income $18.0M ($0.10 adj diluted EPS).
WisdomTree appoints Rilla Delorier to Board as Class I director, effective Aug 18, 2023
Board expanded to 10 directors; Delorier's term expires at 2024 annual meeting.
WisdomTree Q2 net income $54.3M ($0.32 diluted EPS); record AUM $93.7B; adjusted EPS $0.09
Diluted EPS $0.32 (GAAP); adjusted EPS $0.09; net income $54.3M including $41.4M non-cash gain from termination of gold payments obligation.
WisdomTree appoints new committee chairs; majority of directors joined in past three years
Audit Committee: Harold Singleton III (Chair), Lynn Blake, Anthony Bossone, Daniela Mielke.
WisdomTree settles shareholder suit over Rights Agreement with $485K fee payment
Plaintiff challenged Rights Agreement provisions; company amended on May 4 to moot claims.
WisdomTree appoints Win Neuger as Chair of the Board
Win Neuger appointed as independent Chair of the Board on June 26, 2023.
Stockholders elected five of six WisdomTree nominees (Blake, Mielke, Neuger, Naidoo, Steinberg) and one of three ETFS Capital nominees (Pankopf).
WisdomTree settles gold payment obligation for ~$137M; 15% EPS accretive, margin up 530 bps
Transaction valued at ~$137M: $50M cash plus 13.1M shares of non-voting convertible preferred stock.
WisdomTree amends stockholder rights agreement; modifies beneficial ownership definition
Amendment effective May 4, 2023 to Rights Agreement dated March 17, 2023.
WisdomTree reports record AUM $90.7B, Q1 net income $16.2M, $6.3B net inflows
Record AUM of $90.7B, net inflows $6.3B (3rd best quarter); diluted EPS $0.10, adjusted EPS $0.07.
WisdomTree adopts limited-duration stockholder rights plan (poison pill) with 10% trigger
Rights plan triggers if any person acquires 10% (20% for passive) or more of common stock.
WisdomTree issues $130M 5.75% Convertible Notes due 2028; net ~$126.4M, conversion ~$9.54
Issued $130M aggregate principal of 5.75% Convertible Senior Notes due 2028; net proceeds ~$126.4M.
WisdomTree prices $130M convertible notes due 2028 at 5.75%, repurchases $115M of 2023 notes
Priced $130M (plus $20M option) 5.75% convertible senior notes due Aug 15, 2028; conversion price $9.54/share (~60% premium to $5.96 close).
WisdomTree announces $130M convertible note offering to repurchase up to $115M of 2023 notes
Offering $130M in convertible senior notes due 2028 to QIBs; initial purchaser option for additional $20M.
On November 8, 2023, the Board appointed Lynn S. Blake, a current member of the Audit Committee, to replace Mr. Singleton as Chair of the Audit Committee.
On November 2, 2023, Harold Singleton III, a member of the Board of Directors (the “Board”) of WisdomTree, Inc. (the “Company”), Chair of the Audit Committee and a member of the Nominating and Governance Committee of the Board, notified the Company of his intention to resign from the Board, effective November 8, 2023.
appointed Rilla Delorier to serve as a Class I member of the Board
the Board of Directors (the “Board”) of WisdomTree Investments, Inc. (the “Company”) appointed Daniela Mielke to serve as a Class II member of the Board, effective September 21, 2022, to fill the vacancy resulting from Susan Cosgrove’s resignation
On August 19, 2022, Susan Cosgrove, a member of the Board of Directors (the “Board”) of WisdomTree Investments, Inc. (the “Company”) and a member of the Audit Committee and Nominating and Governance Committee of the Board, notified the Company of her intention to resign from the Board, effective September 15, 2022.
appointed Lynn S. Blake and Deborah A. Fuhr to the Board, effective immediately
appointed Lynn S. Blake and Deborah A. Fuhr to the Board, effective immediately
On January 21, 2022, the Board of Directors (the “Board”) of WisdomTree Investments, Inc. (the “Company”) appointed Harold Singleton III to serve as a Class I member of the Board
Effective January 12, 2022, Bruce Lavine resigned from the Board of Directors of WisdomTree Investments, Inc. (the “Company”) and from the Nominating and Governance Committee of the Board.
Max materiality 0.85 · Median 0.68 · Most common event other_material